Genome-wide screen yields new gene therapies to protect against retinal degeneration

AI Summary

Research from Washington University has identified new neuroprotective genes which have the potential to be used in gene therapies aimed at treating retinal degeneration. These findings may lead to innovative strategies for maintaining retinal health.

Researchers in the WashU Medicine Department of Ophthalmology & Visual Sciences have discovered key neuroprotective genes that could lead to the development of gene therapies to treat retinitis pigmentosa, an inherited form of retinal degeneration that causes blindness. The findings, published in Neuron, point to new therapeutic strategies to maintain retinal health and protect against degeneration.